SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001539497-22-000793
Filing Date
2022-04-11
Accepted
2022-04-11 07:11:42
Documents
67
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K n2583-x37_10k.htm   iXBRL 10-K 1208825
  Complete submission text file 0001539497-22-000793.txt   6127604

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE bixt-20211231.xsd EX-101.SCH 59017
3 XBRL CALCULATION FILE bixt-20211231_cal.xml EX-101.CAL 46911
4 XBRL DEFINITION FILE bixt-20211231_def.xml EX-101.DEF 237177
5 XBRL LABEL FILE bixt-20211231_lab.xml EX-101.LAB 368490
6 XBRL PRESENTATION FILE bixt-20211231_pre.xml EX-101.PRE 337075
61 EXTRACTED XBRL INSTANCE DOCUMENT n2583-x37_10k_htm.xml XML 930694
Mailing Address C/O BIOXYTRAN, INC. 75 2ND AVE, SUITE 605 STE 605 NEEDHAM MA 02494
Business Address C/O BIOXYTRAN, INC. 75 2ND AVE, SUITE 605 STE 605 NEEDHAM MA 02494 617-494-1199
BIOXYTRAN, INC (Filer) CIK: 0001445815 (see all company filings)

IRS No.: 262797630 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35027 | Film No.: 22818476
SIC: 2834 Pharmaceutical Preparations